StockData
ProQR Therapeutics N.V. logo

ProQR Therapeutics N.V. (PRQR) stock

PRQRNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 20-F on Mar 12, 2026Score 7/30
$1.10−0.05 (-4.35%)

Close on Nov 18, 2026Market cap $115.90MP/E –Yield –

ProQR Therapeutics price to book ratio

The price-to-book ratio is market cap divided by shareholders' equity.

ProQR Therapeutics's price to book ratio was 1.5× on Nov 11, 2026, against 3.7× a year earlier. Over the last 5 years it ranged from 0.4× to 11.9×, with a median of 2.5×.

Price to Book Ratio at the end of each year

PeriodPeriod endValueChange (pts)
2026Nov 11, 20261.5×−1.6
2025Dec 31, 20253.1×−5.2
2024Dec 31, 20248.4×+5.3
2023Dec 29, 20233.0×−0.8
2022Dec 30, 20223.8×+0.6
2021Dec 31, 20213.2×+0.8
2020Dec 31, 20202.5×−3.9
2019Dec 31, 20196.4×−15.6
2018Dec 31, 201821.9×+20.8
2017Dec 29, 20171.2×–

More ProQR Therapeutics figures

See a number that looks wrong?